Search research articles
Contact Us
Filters
Showing results (161-170 of 280) with videos related to
Page
of 28
Sort By:
Plos One
|
February 8, 2017
Comprehensive mapping of antigen specific T cell responses in hepatitis C virus infected patients with or without spontaneous viral clearance
Chao Zhang, Rui Hua, Yuanyuan Cui, et al.
Virology Journal
|
December 20, 2024
Safety, pharmacokinetics, and antiviral efficacy of the novel capsid assembly modulator GST-HG141 in patients with chronic hepatitis B: a phase 1 trial with a randomized, placebo-controlled design
Min Wu, Jiajia Mai, Hong Zhang, et al.
Expert Opinion on Investigational Drugs
|
January 22, 2026
A randomized, double-blind, placebo-controlled study to evaluate the safety, pharmacokinetics and ammonia-lowering effect of Rifaquizinone, an intestinally restricted investigational drug
Mengdi Lu, Jing Chen, Hong Zhang, et al.
Gastroenterology Report
|
June 27, 2025
Metabolic dysfunction-associated steatotic liver disease is associated with the risk of severe liver fibrosis in pediatric population
Wei Li, Lina Jiang, Meiling Li, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
February 4, 2026
Early treatment initiation optimizes virologic and liver outcomes in pediatric patients with chronic hepatitis B aged 0-18 years
Lin Chen, Lina Jiang, Bokang Zhao, et al.
Immunologic Research
|
November 20, 2017
Screening HCV genotype-specific epitope peptides based on conserved sequence analysis and B cell epitope prediction in HCV E2 region
Rui Hua, Xiaoyu Jiang, Lingxia Qi, et al.
Cellular & Molecular Immunology
|
February 15, 2017
Type I IFN augments IL-27-dependent TRIM25 expression to inhibit HBV replication
Guangyun Tan, Qingfei Xiao, Hongxiao Song, et al.
Ebiomedicine
|
July 27, 2019
Detection of residual HCV-RNA in patients who have achieved sustained virological response is associated with persistent histological abnormality
Yijin Wang, Huiying Rao, Xiumei Chi, et al.
Scientific Reports
|
October 28, 2016
HCV core protein inhibits polarization and activity of both M1 and M2 macrophages through the TLR2 signaling pathway
Qianqian Zhang, Yang Wang, Naicui Zhai, et al.
Plos Pathogens
|
March 22, 2014
Hepatitis B virus infection and immunopathogenesis in a humanized mouse model: induction of human-specific liver fibrosis and M2-like macrophages
Moses T Bility, Liang Cheng, Zheng Zhang, et al.
Page
of 28
Search research articles
Search
Showing results (161-170 of 280) with videos related to
Sort By:
Page
of 28
Plos One
|
February 8, 2017
Comprehensive mapping of antigen specific T cell responses in hepatitis C virus infected patients with or without spontaneous viral clearance
Chao Zhang, Rui Hua, Yuanyuan Cui, et al.
Virology Journal
|
December 20, 2024
Safety, pharmacokinetics, and antiviral efficacy of the novel capsid assembly modulator GST-HG141 in patients with chronic hepatitis B: a phase 1 trial with a randomized, placebo-controlled design
Min Wu, Jiajia Mai, Hong Zhang, et al.
Expert Opinion on Investigational Drugs
|
January 22, 2026
A randomized, double-blind, placebo-controlled study to evaluate the safety, pharmacokinetics and ammonia-lowering effect of Rifaquizinone, an intestinally restricted investigational drug
Mengdi Lu, Jing Chen, Hong Zhang, et al.
Gastroenterology Report
|
June 27, 2025
Metabolic dysfunction-associated steatotic liver disease is associated with the risk of severe liver fibrosis in pediatric population
Wei Li, Lina Jiang, Meiling Li, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
February 4, 2026
Early treatment initiation optimizes virologic and liver outcomes in pediatric patients with chronic hepatitis B aged 0-18 years
Lin Chen, Lina Jiang, Bokang Zhao, et al.
Immunologic Research
|
November 20, 2017
Screening HCV genotype-specific epitope peptides based on conserved sequence analysis and B cell epitope prediction in HCV E2 region
Rui Hua, Xiaoyu Jiang, Lingxia Qi, et al.
Cellular & Molecular Immunology
|
February 15, 2017
Type I IFN augments IL-27-dependent TRIM25 expression to inhibit HBV replication
Guangyun Tan, Qingfei Xiao, Hongxiao Song, et al.
Ebiomedicine
|
July 27, 2019
Detection of residual HCV-RNA in patients who have achieved sustained virological response is associated with persistent histological abnormality
Yijin Wang, Huiying Rao, Xiumei Chi, et al.
Scientific Reports
|
October 28, 2016
HCV core protein inhibits polarization and activity of both M1 and M2 macrophages through the TLR2 signaling pathway
Qianqian Zhang, Yang Wang, Naicui Zhai, et al.
Plos Pathogens
|
March 22, 2014
Hepatitis B virus infection and immunopathogenesis in a humanized mouse model: induction of human-specific liver fibrosis and M2-like macrophages
Moses T Bility, Liang Cheng, Zheng Zhang, et al.
Page
of 28